RC48-ADC in HER2-low Advanced Breast Cancer
NCT05831878
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Advanced Breast Cancer
Interventions
DRUG:
Disitamab vedotin
Sponsor
RenJi Hospital